Cargando…

147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine

BACKGROUND: Our investigation aimed to visualize the 3-D spatial distribution of nasal cavity mucosal swelling under levocetirizine prophylactic treatment on exposure to allergens. This study made use of standard rhinologic diagnostics such as rhinomanometry and acoustic rhinometry, as well as 24 ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Achilles, Nils, Moesges, Ralph, El Hassan, Eelaf, Wein, Berthold, Schröder, Wolgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512940/
http://dx.doi.org/10.1097/01.WOX.0000411892.75019.4c
_version_ 1782251837949214720
author Achilles, Nils
Moesges, Ralph
El Hassan, Eelaf
Wein, Berthold
Schröder, Wolgang
author_facet Achilles, Nils
Moesges, Ralph
El Hassan, Eelaf
Wein, Berthold
Schröder, Wolgang
author_sort Achilles, Nils
collection PubMed
description BACKGROUND: Our investigation aimed to visualize the 3-D spatial distribution of nasal cavity mucosal swelling under levocetirizine prophylactic treatment on exposure to allergens. This study made use of standard rhinologic diagnostics such as rhinomanometry and acoustic rhinometry, as well as 24 hours rhinometry and magnetic resonance imaging (MRI). METHODS: A suitable test subject with a history of allergic rhinitis was identified during the symptom-free interval after the pollen season when she showed signs of “minimal persistent inflammation,” consisting of pronounced reaction to nasal challenge with allergens. Provocation with birch pollen caused moderate symptoms of allergic rhinitis. Nasal provocation tests were performed before and after 2 and 5 weeks of treatment with levocetirizine 5 mg OD. Long-term rhinometry was carried out to detect the progress of the nasal cycle and relative flow variances over 24 hours. Flexible air tubes required for this new procedure made it possible to quantify relative pressure changes. High resolution MRI was also used to capture, visualize, and process the geometrical data of the nasal cavity immediately before and after the challenge tests. Based upon the MRI data, we computed the nasal airflow using a computational fluid dynamics (CFD) nasal model to visualize intranasal pressure and flow. Rhinomanometry and acoustic rhinometry were performed to validate the results. RESULTS: After 36 days of treatment with levocetirizine, a 16% improvement in the nasal flow relative to baseline and an increase by 3.4 cm(3) of the total nasal baseline volume were documented as compared to the allergen challenge of the untreated case. 3-D images illustrated that treatment inhibited the allergen provocation effects on nasal airflow and normalised nasal flow velocity and pressure, including in the olfactory region. CONCLUSIONS: Besides improving the nasal airflow to an almost normal pattern, levocetirizine also helps prevents the patient from having an allergic response, even 24 hours after last drug intake. Furthermore, it can improve olfaction by restoring airflow to the olfactory region.
format Online
Article
Text
id pubmed-3512940
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35129402012-12-21 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine Achilles, Nils Moesges, Ralph El Hassan, Eelaf Wein, Berthold Schröder, Wolgang World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Our investigation aimed to visualize the 3-D spatial distribution of nasal cavity mucosal swelling under levocetirizine prophylactic treatment on exposure to allergens. This study made use of standard rhinologic diagnostics such as rhinomanometry and acoustic rhinometry, as well as 24 hours rhinometry and magnetic resonance imaging (MRI). METHODS: A suitable test subject with a history of allergic rhinitis was identified during the symptom-free interval after the pollen season when she showed signs of “minimal persistent inflammation,” consisting of pronounced reaction to nasal challenge with allergens. Provocation with birch pollen caused moderate symptoms of allergic rhinitis. Nasal provocation tests were performed before and after 2 and 5 weeks of treatment with levocetirizine 5 mg OD. Long-term rhinometry was carried out to detect the progress of the nasal cycle and relative flow variances over 24 hours. Flexible air tubes required for this new procedure made it possible to quantify relative pressure changes. High resolution MRI was also used to capture, visualize, and process the geometrical data of the nasal cavity immediately before and after the challenge tests. Based upon the MRI data, we computed the nasal airflow using a computational fluid dynamics (CFD) nasal model to visualize intranasal pressure and flow. Rhinomanometry and acoustic rhinometry were performed to validate the results. RESULTS: After 36 days of treatment with levocetirizine, a 16% improvement in the nasal flow relative to baseline and an increase by 3.4 cm(3) of the total nasal baseline volume were documented as compared to the allergen challenge of the untreated case. 3-D images illustrated that treatment inhibited the allergen provocation effects on nasal airflow and normalised nasal flow velocity and pressure, including in the olfactory region. CONCLUSIONS: Besides improving the nasal airflow to an almost normal pattern, levocetirizine also helps prevents the patient from having an allergic response, even 24 hours after last drug intake. Furthermore, it can improve olfaction by restoring airflow to the olfactory region. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512940/ http://dx.doi.org/10.1097/01.WOX.0000411892.75019.4c Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Achilles, Nils
Moesges, Ralph
El Hassan, Eelaf
Wein, Berthold
Schröder, Wolgang
147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title_full 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title_fullStr 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title_full_unstemmed 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title_short 147 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
title_sort 147 3-d visualization of the anti-obstructive effect of levocetirizine
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512940/
http://dx.doi.org/10.1097/01.WOX.0000411892.75019.4c
work_keys_str_mv AT achillesnils 1473dvisualizationoftheantiobstructiveeffectoflevocetirizine
AT moesgesralph 1473dvisualizationoftheantiobstructiveeffectoflevocetirizine
AT elhassaneelaf 1473dvisualizationoftheantiobstructiveeffectoflevocetirizine
AT weinberthold 1473dvisualizationoftheantiobstructiveeffectoflevocetirizine
AT schroderwolgang 1473dvisualizationoftheantiobstructiveeffectoflevocetirizine